CD24 and cancer: To determine whether the metastatic ability of the 4T1 murine tumours demonstrates both an epithelial–mesenchymal transition (EMT) phenotype and had cancer stem cell (CSC) properties, we used the CD29 and CD24 murine mammary stem cell markers as previously described17.